Blog
Something inspiring would go here to explain the blog.
-
Eight in 10 Doctors Concerned About Impact of Tariffs on Patients
By
In this article by the Canadian Medical Association, survey results show 88% of doctors worry about how tariffs will affect patients. Many of those surveyed cited rising costs of medications, […]
-
Life on Hold – How Canada’s Drug Approval Delays Endanger Patients
By
In this article by Nigel Rawson and John Adams for the Macdonald-Laurier Institute, they explore how Canada’s slow approval and reimbursement systems delay patient access to new medicines for years. […]
-
Canada Supports Biomanufacturing Capacity to Advance Next Generation Medicines
By
In March 2025, the Government of Canada announced a $62 million investment to build a 103,000-square-foot facility in Edmonton to scale up production of therapeutics and vaccines. The facility will […]
-
Government of Canada Invests in Southern Ontario’s Life Sciences Sector
By
In February 2025, the Government of Canada announced an over $16 million investment in six life sciences organizations in Southern Ontario to support research, commercial scale-up, and innovation infrastructure. The […]
-
Canada’s National Pharmacare Plan – Boon or Bane?
By
In this article by Nigel Rawson & John Adams, readers learn that with national pharmacare, Canada still faces serious barriers in approval, reimbursement, and government plan listings. The commentary warns […]